We are live on ! Find out more

3,235 hedge funds and large institutions have $216B invested in Merck in 2022 Q4 according to their latest regulatory filings, with 393 funds opening new positions, 1,189 increasing their positions, 1,326 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

318% more first-time investments, than exits

New positions opened: 393 | Existing positions closed: 94

53% more funds holding in top 10

Funds holding in top 10: 224342 (+118)

32% more capital invested

Capital invested by funds: $163B → $216B (+$52.9B)

8% more funds holding

Funds holding: 2,9903,235 (+245)

4% more call options, than puts

Call options by funds: $2.63B | Put options by funds: $2.53B

0.45% more ownership

Funds ownership: 75.08%75.53% (+0.45%)

10% less repeat investments, than reductions

Existing positions increased: 1,189 | Existing positions reduced: 1,326

Holders
3,235
Holders Change
+245
Holders Change %
+8.19%
% of All Funds
51.99%
Holding in Top 10
342
Holding in Top 10 Change
+118
Holding in Top 10 Change %
+52.68%
% of All Funds
5.5%
New
393
Increased
1,189
Reduced
1,326
Closed
94
Calls
$2.63B
Puts
$2.53B
Net Calls
+$98.2M
Net Calls Change
-$528M
Name Holding Trade Value Shares
Change
Change in
Stake
CIBC Asset Management
276
CIBC Asset Management
Ontario, Canada
$59.1M -$11.1M -109,023 -17%
UCFA
277
United Capital Financial Advisors
Texas
$59M +$142K +1,385 +0.3%
BBVA
278
Banco Bilbao Vizcaya Argentaria
Spain
$58.7M +$8.41M +82,235 +18%
AAP
279
Aristotle Atlantic Partners
Florida
$58.4M
MNG
280
Manning & Napier Group
New York
$58M -$1.34M -13,125 -2%
RG
281
Rathbones Group
United Kingdom
$57.8M +$17.7M +173,021 +50%
MML Investors Services
282
MML Investors Services
Massachusetts
$57.5M +$1.61M +15,767 +3%
WP
283
Woodline Partners
California
$56.8M -$47.6M -466,152 -48%
Carson Wealth (CWM LLC)
284
Carson Wealth (CWM LLC)
Nebraska
$56.7M +$1.44M +14,074 +3%
SI
285
Stephens Inc
Arkansas
$56.6M +$1.47M +14,425 +3%
DP
286
Dearborn Partners
Illinois
$56.3M -$474K -4,637 -0.9%
SW
287
SVB Wealth
Massachusetts
$55.3M -$3.06M -29,977 -6%
MF
288
Magnetar Financial
Illinois
$55.3M -$27.9M -273,261 -35%
Mercer Global Advisors
289
Mercer Global Advisors
Colorado
$54.9M +$6.87M +67,226 +16%
VMPIC
290
Varma Mutual Pension Insurance Co
Finland
$54.7M +$5.11M +50,000 +11%
CIBC Private Wealth Group
291
CIBC Private Wealth Group
Georgia
$53.8M +$4.11M +40,184 +4%
WBC
292
Westpac Banking Corp
Australia
$53.5M +$7.86M +76,911 +19%
CPC
293
Cookson Peirce & Co
Pennsylvania
$53.4M +$31.9M +311,855 +185%
Cambridge Investment Research Advisors
294
Cambridge Investment Research Advisors
Iowa
$53.1M +$3.23M +31,619 +7%
FPCG
295
Fort Pitt Capital Group
Pennsylvania
$52M +$445K +4,358 +0.9%
SC
296
Saturna Capital
Washington
$51.9M +$46M +449,810 +2,503%
TAM
297
Trillium Asset Management
Massachusetts
$51.9M -$1.06M -10,419 -2%
II
298
IFM Investors
Australia
$51.7M +$2.93M +28,701 +7%
SMDAM
299
Sumitomo Mitsui DS Asset Management
Japan
$51.2M +$1.78M +17,438 +4%
BF
300
BOK Financial
Oklahoma
$51.1M +$2.77M +27,057 +6%

MRK Hedge Fund Activity: Q4 2022 in Review

3,235 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2022, worth a combined $216B — up 32% from $163B a quarter earlier.

Buyers outnumbered sellers: 393 funds opened new MRK positions and 94 closed out — a net gain of 299 holders — while 1,189 added to existing stakes and 1,326 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $2.23B. The largest seller was Janus Henderson Group, cutting an estimated $1.43B.

  • 3,235 institutional investors held Merck (MRK) as of Q4 2022, up from 2,990 in Q3 2022.
  • Funds reported $216B of Merck stock for Q4 2022, up 32% quarter-over-quarter.
  • 393 funds opened new Merck positions in Q4 2022 and 94 closed out, a net change of +299 holders.
  • The largest Merck buyer in Q4 2022 was Wellington Management Group, an estimated $2.23B added.
  • The largest Merck seller in Q4 2022 was Janus Henderson Group, an estimated $1.43B sold.

Based on aggregated 13F filings for Q4 2022.